Signalosomes as therapeutic targets

Progress in Pediatric Cardiology

Volumn 25, Issue 1, 2008, Pages 51-56

  Negro, Alejandra ^a   Dodge Kafka, Kimberly ^b   Kapiloff, Michael S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

AKAP lbc; Heart; mAKAP; Signalosome; Therapeutic

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; SCAFFOLD PROTEIN; SIGNALOSOME; UNCLASSIFIED DRUG;

ARTICLE; CELL SIZE; EMERY DREIFUSS MUSCULAR DYSTROPHY; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 40949111015     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.11.012     Document Type: Article

References (43)

1. Heineke J., and Molkentin J. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7 (2006) 589-600
2. Clerk A., Cullingford T., Fuller S., et al. Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses. J Cell Physiol 212 (2007) 311-322
3. Steinberg S., and Brunton L. Compartmentation of g protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol 41 (2001) 751-773
4. Smith F., Langeberg L., and Scott J. The where's and when's of kinase anchoring. Trends Biochem Sci 31 (2006) 316-323
5. Bauman A., Michel J., Henson E., et al. The mAKAP signalosome and cardiac myocyte hypertrophy. IUBMB Life 59 (2007) 163-169
6. Diviani D., Baisamy L., and Appert-Collin A. AKAP-Lbc: a molecular scaffold for the integration of cyclic AMP and Rho transduction pathways. Eur J Cell Biol 85 (2006) 603-610
7. Barnes S., Shields B., Bonney W., et al. The pediatric cardiology pharmacopoeia: 2004 update. Pediatr Cardiol 25 (2004) 623-646
8. Buxton I., and Brunton L. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. J Biol Chem 258 (1983) 10233-10239
9. Michel J., and Scott J. Akap mediated signal transduction. Annu Rev Pharmacol Toxicol 42 (2002) 235-257
10. Fraser I., Tavalin S., Lester L., et al. A novel lipid-anchored A-kinase Anchoring Protein facilitates cAMP-responsive membrane events. EMBO J 17 (1998) 2261-2272
11. Hulme J., Westenbroek R., Scheuer T., et al. Phosphorylation of serine 1928 in the distal C-terminal domain of cardiac CaV1.2 channels during beta1-adrenergic regulation. Proc Natl Acad Sci USA 103 (2006) 16574-16579
12. McCartney S., Little B., Langeberg L., et al. Cloning and characterization of A-kinase anchor protein 100 (AKAP100). A protein that targets A-kinase to the sarcoplasmic reticulum. J Biol Chem 270 (1995) 9327-9333
13. Yang J., Drazba J., Ferguson D., et al. A-kinase anchoring protein 100 (AKAP100) is localized in multiple subcellular compartments in the adult rat heart. J Cell Biol 142 (1998) 511-522
14. Marx S., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
15. Kapiloff M., Schillace R., Westphal A., et al. mAKAP: an A-kinase anchoring protein targeted to the nuclear membrane of differentiated myocytes. J Cell Sci 112 (1999) 2725-2736
16. Kapiloff M., Jackson N., and Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci 114 (2001) 3167-3176
17. Pare G., Easlick J., Mislow J., et al. Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope. Exp Cell Res 303 (2005) 388-399
18. Zhang Q., Bethmann C., Worth N., et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery-Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet (2007)
19. Dodge K., Khouangsathiene S., Kapiloff M., et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J 20 (2001) 1921-1930
20. Terrin A., Di Benedetto G., Pertegato V., et al. PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol 175 (2006) 441-451
21. Carlisle Michel J., Dodge K., Wong W., et al. PKA-phosphorylation of PDE4D3 facilitates recruitment of the mAKAP signalling complex. Biochem J 381 (2004) 587-592
22. Dodge-Kafka K., Soughayer J., Pare G., et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature 437 (2005) 574-578
23. Yan C., Ding B., Shishido T., et al. Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop. Circ Res 100 (2007) 510-519
24. Nicol R., Frey N., Pearson G., et al. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 20 (2001) 2757-2767
25. MacKenzie S., Baillie G., McPhee I., et al. ERK2 mitogen-activated protein kinase binding, phosphorylation, and regulation of the PDE4D cAMP-specific phosphodiesterases. The involvement of COOH-terminal docking sites and NH2-terminal UCR regions. J Biol Chem 275 (2000) 16609-16617
26. Manabe I., Shindo T., and Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91 (2002) 1103-1113
27. Bers D. Cardiac ryanodine receptor phosphorylation: target sites and functional consequences. Biochem J 396 (2006) e1-e3
28. Wehrens X., Lehnart S., Reiken S., et al. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A 103 (2006) 511-518
29. 2+ store throughout cardiac myocyte. Circ Res 99 (2006) 283-291
30. Pare G., Bauman A., McHenry M., et al. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling. J Cell Sci 118 (2005) 5637-5646
31. Wilkins B., and Molkentin J. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun 322 (2004) 1178-1191
32. Appert-Collin A., Cotecchia S., Nenniger-Tosato M., et al. The A-kinase anchoring protein (AKAP)-Lbc-signaling complex mediates alpha1 adrenergic receptor-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 104 (2007) 10140-10145
33. Carr D., Hausken Z., Fraser I., et al. Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII- binding domain. J Biol Chem 267 (1992) 13376-13382
34. Newlon M., Roy M., Morikis D., et al. A novel mechanism of PKA anchoring revealed by solution structures of anchoring complexes. EMBO J 20 (2001) 1651-1662
35. Diviani D., Soderling J., and Scott J. AKAP-Lbc Anchors Protein Kinase A and Nucleates Galpha 12-selective Rho- mediated Stress Fiber Formation. J Biol Chem 276 (2001) 44247-44257
36. Diviani D., Abuin L., Cotecchia S., et al. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J 23 (2004) 2811-2820
37. Jin J., Smith F., Stark C., et al. Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol 14 (2004) 1436-1450
38. Maruyama Y., Nishida M., Sugimoto Y., et al. Galpha(12/13) mediates alpha(1)-adrenergic receptor-induced cardiac hypertrophy. Circ Res 91 (2002) 961-969
39. Carnegie G., Smith F., McConnachie G., et al. AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell 15 (2004) 889-899
40. de Fougerolles A., Vornlocher H., Maraganore J., et al. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6 (2007) 443-453
41. Dodge-Kafka K., and Kapiloff M. The mAKAP signaling complex: integration of cAMP, calcium, and MAP kinase signaling pathways. Eur J Cell Biol 85 (2006) 593-602
42. Martinez-Martinez S., and Redondo J. Inhibitors of the calcineurin/NFAT pathway. Curr Med Chem 11 (2004) 997-1007
43. Yu H., van Berkel T., and Biessen E. Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders. Cardiovasc Drug Rev 25 (2007) 175-187